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GliomaA prospective study was performed on neurosurgical samples from 18 patients to evaluate the use of full-ﬁeld
optical coherence tomography (FF-OCT) in brain tumor diagnosis.
FF-OCT captures en face slices of tissue samples at 1 μm resolution in 3D to a penetration depth of around
200 μm. A 1 cm2 specimen is scanned at a single depth and processed in about 5 min. This rapid imaging
process is non-invasive and requires neither contrast agent injection nor tissue preparation, which makes
it particularly well suited to medical imaging applications.
Temporal chronic epileptic parenchyma and brain tumors such as meningiomas, low-grade and high-grade
gliomas, and choroid plexus papilloma were imaged. A subpopulation of neurons, myelin ﬁbers and CNS vas-
culature were clearly identiﬁed. Cortex could be discriminated from white matter, but individual glial cells
such as astrocytes (normal or reactive) or oligodendrocytes were not observable.
This study reports for the ﬁrst time on the feasibility of using FF-OCT in a real-time manner as a label-free
non-invasive imaging technique in an intraoperative neurosurgical clinical setting to assess tumorous glial
and epileptic margins.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license.1. Introduction
1.1. Primary CNS tumors
Primary central nervous system (CNS) tumors represent a hetero-
geneous group of tumors with benign, malignant and slow-growing
evolution. In France, 5000 new cases of primary CNS tumors are
detected annually (Rigau et al., 2011). Despite considerable progress
in diagnosis and treatment, the survival rate following a malignant
brain tumor remains low and 3000 deaths are reported annually
from CNS tumors in France (INCa, 2011). Overall survival from brain
tumors depends on the complete resection of the tumor mass, as
identiﬁed through postoperative imaging, associated with updated
adjuvant radiation therapy and chemotherapy regimen for malignantmography; OCT, optical coher-
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nc. Open access under CC BY-NC-SA lictumors (Sofﬁetti et al., 2010). Therefore, there is a need to evaluate
the completeness of the tumor resection at the end of the surgical
procedure, as well as to identify the different components of the
tumor interoperatively, i.e. tumor tissue, necrosis, inﬁltrated paren-
chyma (Kelly et al., 1987). In particular, the persistence of non-visible
tumorous tissue or isolated tumor cells inﬁltrating brain parenchyma
may lead to additional resection.
For low-grade tumors located close to eloquent brain areas, a
maximally safe resection that spares functional tissue warrants the
current use of intraoperative techniques that guide a more complete
tumor resection. During awake surgery, speech or ﬁne motor skills
aremonitored, while cortical and subcortical stimulations are performed
to identify functional areas (Sanai et al., 2008). Intraoperative MRI pro-
vides images of the surgical site as well as tomographic images of the
whole brain that are sufﬁcient for an approximate evaluation of the ab-
normal excised tissue, but offers low resolution (typically 1 to 1.5 mm)
and produces artifacts at the air-tissue boundary of the surgical site.
Histological and immunohistochemical analyses of neurosurgical
samples remain the current gold standard method used to analyze tu-
morous tissue due to advantages of sub-cellular level resolution and
high contrast. However, these methods require lengthy (12 to 72 h),
complex multiple steps, and use of carcinogenic chemical products
that would not be technically possible intra-operatively. In addition,
the number of histological slides that can be reviewed and analyzedense.
550 O. Assayag et al. / NeuroImage: Clinical 2 (2013) 549–557by a pathologist is limited, and it deﬁnes the number and size of sam-
pled locations on the tumor, or the surrounding tissue.
To obtain histology-like information in a short time period,
intraoperative cytological smear tests are performed. However tissue
architecture information is thereby lost and the analysis is carried out
on only a limited area of the sample (1 mm × 1 mm).
Intraoperative optical imaging techniques are recently developed
high resolution imaging modalities that may help the surgeon to
identify the persistence of tumor tissue at the resection boundaries.
Using a conventional operating microscope with Xenon lamp illumi-
nation gives an overall view of the surgical site, but performance is
limited by the poor discriminative capacity of the white light illumi-
nation at the surgical site interface. Better discrimination between
normal and tumorous tissues has been obtained using ﬂuorescence
properties of tumor cells labeled with preoperatively administered
5-ALA. Tumor tissue shows a strong ALA-induced PPIX ﬂuorescence
at 635 nm and 704 nm when the operative ﬁeld is illuminated with
a 440 nm-ﬁltered lamp. More complete resections of high-grade glio-
mas have been demonstrated using 5-ALA ﬂuorescence guidance
(Stummer et al., 2000), however brain parenchyma inﬁltrated by iso-
lated tumor cells is not ﬂuorescent, reducing the interest of this tech-
nique when resecting low-grade gliomas.
Reﬁnement of this induced ﬂuorescence technique has been
achieved using a confocal microscope and intraoperative injection of
sodium ﬂuorescein. A 488 nm laser illuminates the operative ﬁeld and
tissue contact analysis is performed using a handheld surgical probe
(ﬁeld of view less than 0.5 × 0.5 mm) which scans the ﬂuorescence of
the surgical interface at the 505–585 nm band. Fluorescent isolated
tumor cells are clearly identiﬁed at depths from 0 to 500 μm from the
resection border (Sanai et al., 2011), demonstrating the potential of
this technique in low-grade glioma resection.
Reviewing the state-of-the-art, a need is identiﬁed for a quick and
reliable method of providing the neurosurgeon with architectural and
cellular information without the need for injection or oral intake of
exogenous markers in order to guide the neurosurgeon and optimize
surgical resections.
1.2. Full-ﬁeld optical coherence tomography
Introduced in the early 1990s (Huang et al., 1991), optical coher-
ence tomography (OCT) uses interference to precisely locate light
deep inside tissue. The photons coming from the small volume of in-
terest are distinguished from light scattered by the other parts of the
sample by the use of an interferometer and a light source with short
coherence length. Only the portion of light with the same path length
as the reference arm of the interferometer, to within the coherence
length of the source (typically a few μm), will produce interference.
A two-dimensional B-scan image is captured by scanning. Recently,
the technique has been improved, mainly in terms of speed and sen-
sitivity, through spectral encoding (De Boer et al., 2003; Leitgeb et al.,
2003; Wojtkowski et al., 2002).
A recent OCT technique called full-ﬁeld optical coherence tomog-
raphy (FF-OCT) enables both a large ﬁeld of view and high resolution
over the full ﬁeld of observation (Dubois et al., 2002, 2004). This al-
lows navigation across the wide ﬁeld image to follow the morphology
at different scales and different positions. FF-OCT uses a simple halogen
or light-emitting diode (LED) light source for full ﬁeld illumination,
rather than lasers and point-by-point scanning components required
for conventional OCT. The illumination level is low enough to maintain
the sample integrity: the power incident on the sample is less than
1 mW/mm2 using deep red and near infrared light. FF-OCT provides
the highest OCT 3D resolution of 1.5 × 1.5 × 1 μm3 (X × Y × Z) on
unprepared label-free tissue samples down to depths of approximately
200 μm–300 μm (tissue-dependent) over a wide ﬁeld of view that
allows digital zooming down to the cellular level. Interestingly, it
produces en face images in the native ﬁeld view (rather than thecross-sectional images of conventional OCT), whichmimic the histology
process, thereby facilitating the reading of images by pathologists.
Moreover, as for conventional OCT, it does not require tissue slicing or
modiﬁcation of any kind (i.e. no tissue ﬁxation, coloration, freezing or
parafﬁn embedding). FF-OCT image acquisition and processing time is
less than 5 min for a typical 1 cm2 sample (Assayag et al., 2013) and
the imaging performance has been shown to be equivalent in fresh
or ﬁxed tissue (Assayag et al., 2013; Dalimier and Salomon, 2012). In
addition, FF-OCT intrinsically provides digital images suitable for
telemedicine.
Numerous studies have been published over the past two decades
demonstrating the suitability of OCT for in vivo or ex vivo diagnosis.
OCT imaging has been previously applied in a variety of tissues such as
the eye (Grieve et al., 2004; Swanson et al., 1993), upper aerodigestive
tract (Betz et al., 2008; Chen et al., 2007; Ozawa et al., 2009), gastrointes-
tinal tract (Tearney et al., 1998), andbreast tissue and lymphnodes (Adie
and Boppart, 2009; Boppart et al., 2004; Hsiung et al., 2007; Luo et al.,
2005; Nguyen et al., 2009; Zhou et al., 2010; Zysk and Boppart, 2006).
In the CNS, published studies that evaluate OCT (Bizheva et al.,
2005; Böhringer et al., 2006, 2009; Boppart, 2003; Boppart et al.,
1998) using time-domain (TD) or spectral domain (SD) OCT systems
had insufﬁcient resolution (10 to 15 μm axial) for visualization of ﬁne
morphological details. A study of 9 patients with gliomas carried out
using a TD-OCT system led to classiﬁcation of the samples as malig-
nant versus benign (Böhringer et al., 2009). However, the differentia-
tion of tissues was achieved by considering the relative attenuation of
the signal returning from the tumorous zones in relation to that
returning from healthy zones. The classiﬁcation was not possible by
real recognition of CNS microscopic structures. Another study showed
images of brainmicrostructures obtainedwith anOCT system equipped
with an ultra-fast laser that offered axial and lateral resolution of 1.3 μm
and 3 μm respectively (Bizheva et al., 2005). In this way, it was possible
to differentiate malignant from healthy tissue by the presence of blood
vessels, microcalciﬁcations and cysts in the tumorous tissue. However
the images obtainedwere small (2 mm × 1 mm), captured onﬁxed tis-
sue only and required use of an expensive large laser thereby limiting
the possibility for clinical implementation.
Other studies have focused on animal brain. In rat brain in vivo, it
has been shown that optical coherence microscopy (OCM) can reveal
neuronal cell bodies and myelin ﬁbers (Srinivasan et al., 2012), while
FF-OCT can also reveal myelin ﬁbers (Ben Arous et al., 2011), and
movement of red blood cells in vessels (Binding et al., 2011).
En face images captured with confocal reﬂectance microscopy
can closely resemble FF-OCT images. For example, a prototype system
used by Wirth et al. (2012) achieves lateral and axial resolution of
0.9 μm and 3 μm respectively. However small ﬁeld size prevents view-
ing of wide-ﬁeld architecture and slow acquisition speed prohibits the
implementation of mosaicking. In addition, the poorer axial resolution
and lower penetration depth of confocal imaging in comparison to
FF-OCT limit the ability to reconstruct cross-sections from the confocal
image stack.
This study is the ﬁrst to analyze non-tumorous and tumorous
human brain tissue samples using FF-OCT.2. Materials and methods
2.1. Instrument
The experimental arrangement of FF-OCT (Fig. 1A) is based on a
conﬁguration that is referred to as a Linnik interferometer (Dubois
et al., 2002). A halogen lamp is used as a spatially incoherent source
to illuminate the full ﬁeld of an immersion microscope objective at
a central wavelength of 700 nm, with spectral width of 125 nm. The
signal is extracted from the background of incoherent backscattered
light using a phase-shifting method implemented in custom-designed
Fig. 1. System schematic (A), photograph (B), sample holder close up (C), and sample close up (D).
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(LightCT, LLTech, France).
Capturing “en face” images allows easy comparison with histolog-
ical sections. The resolution, pixel number and sampling require-
ments result in a native ﬁeld of view that is limited to about 1 mm2.
The sample is moved on a high precision mechanical platform and a
number of ﬁelds are stitched together (Beck et al., 2000) to display
a signiﬁcant ﬁeld of view. The FF-OCT microscope is housed in a com-
pact setup (Fig. 1B) that is about the size of a standard optical micro-
scope (310 × 310 × 800 mm L × W × H).
2.2. Imaging protocol
All images presented in this study were captured on fresh brain
tissue samples from patients operated on at the Neurosurgery De-
partment of Sainte-Anne Hospital, Paris. Informed and written con-
sent was obtained in all cases following the standard procedure at
Sainte-Anne Hospital from patients who were undergoing surgical in-
tervention. Fresh samples were collected from the operating theater
immediately after resection and sent to the pathology department.
A pathologist dissected each sample to obtain a 1–2 cm2 piece and
made a macroscopic observation to orientate the specimen in order
to decide which side to image. The sample was immersed in physio-
logical serum, placed in a cassette, numbered, and brought to the
FF-OCT imaging facility in a nearby laboratory (15 min distant)
where the FF-OCT images were captured. The sample was placed in
a custom holder with a coverslip on top (Fig. 1C, D). The sample
was raised on a piston to rest gently against the coverslip in order
to ﬂatten the surface and so optimize the image capture. The sample
is automatically scanned under a 10 × 0.3 numerical aperture (NA)
immersion microscope objective. The immersion medium is a silicone
oil of refractive index close to that of water, chosen to optimize index
matching and slow evaporation. The entire area of each sample wasimaged at a depth of 20 μm beneath the sample surface. This depth
has been reported to be optimal for comparison of FF-OCT images to
histology images in a previous study on breast tissue (Assayag et al.,
2013). There are several reasons for the choice of imaging depth:
ﬁrstly, histology was also performed at approximately 20 μm from
the edge of the block, i.e. the depth at which typically the whole tis-
sue surface begins to be revealed. Secondly, FF-OCT signal is attenuat-
ed with depth due to multiple scattering in the tissue, and resolution
is degraded with depth due to aberrations. The best FF-OCT images
are therefore captured close to the surface, and the best matching is
achieved by attempting to image at a similar depth as the slice in
the parafﬁn block. It was also possible to capture image stacks down
to several hundred μm in depth (where penetration depth is depen-
dent on tissue type), for the purpose of reconstructing a 3D volume
and imaging layers of neurons and myelin ﬁbers. An example of
such a stack in the cerebellum is shown as a video (Video 2) in supple-
mentarymaterial. Once FF-OCT imagingwas done, each samplewas im-
mediately ﬁxed in formaldehyde and returned to the pathology
department where it underwent standard processing in order to com-
pare the FF-OCT images to histology slides.2.3. Matching FF-OCT to histology
The intention in all cases was to match as closely as possible to
histology. FF-OCT images were captured 20 μm below the surface.
Histology slices were captured 20 μm from the edge of the block.
However the angle of the inclusion is hard to control and so some
difference in the angle of the plane always exists when attempting
matching. Various other factors that can cause differences stem
from the histology process — ﬁxing, dehydrating, parafﬁn inclusion
etc. all alter the tissue and so precise correspondence can be challeng-
ing. Such difﬁculties are common in attempting to match histology to
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Bizheva et al., 2005; confocal microscopy Wirth et al., 2012).
An additional parameter in the matching process is the slice thick-
ness. Histology slides were 4 μm in thickness while FF-OCT optical
slices have a 1 μm thickness. The ﬁner slice of the FF-OCT image
meant that lower cell densities were perceived on the FF-OCT images
(in those cases where individual cells were seen, e.g. neurons in the
cortex). This difference in slice thickness affects the accuracy of the
FF-OCT to histology match. In order to improve matching, it would
have been possible to capture four FF-OCT slices in 1 μm steps and
sum the images to mimic the histology thickness. However, this
would effectively degrade the resolution, which was deemed undesir-
able in evaluating the capacities of the FF-OCT method.
3. Results
18 samples from 18 adult patients (4 males, 14 females) of age
range 19–81 years have been included in the study: 1 mesial temporal
lobe epilepsy and 1 cerebellum adjacent to a pulmonary adenocarcino-
ma metastasis (serving as the non-tumor brain samples), 7 diffuse
supratentorial gliomas (4WHO grade II, 3 WHO grade III), 5 meningio-
mas, 1 hemangiopericytoma, and 1 choroid plexus papilloma. Patient
characteristics are detailed in Table 1.
3.1. FF-OCT imaging identiﬁes myelinated axon ﬁbers, neuronal cell
bodies and vasculature in the human epileptic brain and cerebellum
The cortex and the white matter are clearly distinguished from
one another (Fig. 2). Indeed, a subpopulation of neuronal cell bodies
(Fig. 2B, C) as well as myelinated axon bundles leading to the white
matter could be recognized (Fig. 2D, E). Neuronal cell bodies appear
as dark triangles (Fig. 2C) in relation to the bright surrounding mye-
linated environment. The FF-OCT signal is produced by backscattered
photons from tissues of differing refractive indices. The number of
photons backscattered from the nuclei in neurons appears to be too
few to produce a signal that allows their differentiation from the cy-
toplasm, and therefore the whole of the cell body (nucleus plus cyto-
plasm) appears dark.
Myelinated axons are numerous, well discernible as small fascicles
and appear as bright white lines (Fig. 2E). As the cortex does not con-
tain many myelinated axons, it appears dark gray. Brain vasculature is
visible (Fig. 2F and G), and small vessels are distinguished by a thinTable 1
Summary of patients, cases, and corresponding ﬁgure key.
Patient number Age Sex Sample type Figure #
R376 20 F Temporal neocortex from mesial temporal
lobe epilepsy
2
R577 54 M Temporal neocortex from mesial temporal
lobe epilepsy
–
R384 19 F Hippocampal formation from mesial
temporal lobe epilepsy
3
R576 49 M Normal cerebellum adjacent to a
pulmonary adenocarcinoma metastasis
4
R377 81 F Fibroblastic meningioma grade 1 –
R378 56 M Atypical meningioma grade 2 –
R393 35 F Transitional meningioma grade 1 –
R512 66 F Atypical meningioma grade 2 5
R517 73 F Atypical meningioma grade 2 –
R518 38 F Hemangiopericytoma grade 2 6
R409 25 M Choroid plexus papilloma 7
R379 25 F Fibrillary astrocytoma grade 2 –
R410 65 F Oligo-astrocytoma grade 3 –
R513 51 F Astrocytoma grade 2 8
R520 40 F Oligo-astrocytoma grade 2 8
R535 40 F Oligo-astrocytoma grade 3 8
R569 32 F Gemistocytic astrocytoma grade 2 –
R573 58 F Oligodendroglioma grade 3 8collagen membrane that appears light gray. Video 1 in supplementary
material shows a movie composed of a series of en face 1 μm thick
optical slices captured over 100 μm into the depth of the cortex tis-
sue. The myelin ﬁbers and neuronal cell bodies are seen in successive
layers.
The different regions of the human hippocampal formation are eas-
ily recognizable (Fig. 3). Indeed, CA1 ﬁeld and its stratum radiatum, CA4
ﬁeld, the hippocampal ﬁssure, the dentate gyrus, and the alveus are
easily distinguishable. Other structures become visible by zooming
in digitally on the FF-OCT image. The large pyramidal neurons of the
CA4 ﬁeld (Fig. 3B) and the granule cells that constitute the stratum
granulosum of the dentate gyrus are visible, as black triangles and as
small round dots, respectively (Fig. 3D).
In the normal cerebellum, the lamellar or foliar pattern of alternat-
ing cortex and central white matter is easily observed (Fig. 4A). By
digital zooming, Purkinje and granular neurons also appear as black
triangles or dots, respectively (Fig. 4C), and myelinated axons are vis-
ible as bright white lines (Fig. 4E). Video 2 in supplementary material
shows a ﬂy-through movie in the reconstructed axial slice orientation
of a cortex region in cerebellum. The Purkinje and granular neurons
are visible down to depths of 200 μm in the tissue.
3.2. FF-OCT images distinguish meningiomas from hemangiopericytoma
in meningeal tumors
The classic morphological features of a meningioma are visible on
the FF-OCT image: large lobules of tumorous cells appear in light gray
(Fig. 5A), demarcated by collagen-rich bundles (Fig. 5B) which are
highly scattering and appear a brilliant white in the FF-OCT images.
The classic concentric tumorous cell clusters (whorls) are very clearly
distinguished on the FF-OCT image (Fig. 5D). In addition the presence
of numerous cell whorls with central calciﬁcations (psammoma bod-
ies) is revealed (Fig. 5F). Collagen balls appear bright white on the
FF-OCT image (Fig. 5H). As the collagen balls progressively calcify,
they are consumed by the black of the calciﬁed area, generating a
target-like image (Fig. 5H). Calciﬁcations appear black in FF-OCT as
they are crystalline and so allow no penetration of photons to their
interior.
Mesenchymal non-meningothelial tumors such as hemangioperi-
cytomas represent a classic differential diagnosis of meningiomas. In
FF-OCT, the hemangiopericytoma is more monotonous in appearance
than the meningiomas, with a highly vascular branching component
with staghorn-type vessels (Fig. 6A, C).
3.3. FF-OCT images identify choroid plexus papilloma
The choroid plexus papilloma appears as an irregular coalescence
of multiple papillas composed of elongated ﬁbrovascular axes cov-
ered by a single layer of choroid glial cells (Fig. 7). By zooming in on
an edematous papilla, the axis appears as a black structure covered
by a regular light gray line (Fig. 7B). If the papilla central axis is hem-
orrhagic, the ﬁne regular single layer is not distinguishable (Fig. 7C).
Additional digital zooming in on the image reveals cellular level infor-
mation, and some nuclei of plexus choroid cells can be recognized.
However, cellular atypia and mitosis are not visible. These represent
key diagnosis criteria used to differentiate choroid plexus papilloma
(grade I) from atypical plexus papilloma (grade II).
3.4. FF-OCT images detect the brain tissue architecture modiﬁcations
generated by diffusely inﬁltrative gliomas
Contrary to the choroid plexus papillomas which have a very dis-
tinctive architecture in histology (cauliﬂower-like aspect), very easily
recognized in the FF-OCT images (Fig. 7A to G), diffusely inﬁltrating
glioma does not present a speciﬁc tumor architecture (Fig. 8) as
they diffusely permeate the normal brain architecture. Hence, the
Fig. 2. Cortex is distinguished from white matter. (A) Cortex appears gray. (B–C) Neuronal cell bodies (arrows), (D–E) myelinated axon bundles (arrow) leading to white matter,
and (F–G) vasculature (arrow). (B and F) Hemalun and phloxin stainings and (D) Luxol blue staining. Rectangles indicate locations of zooms. Scale bars show 500 μm (A), 50 μm
(B, C, F, G) and 80 μm (D, E).
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brain parenchyma (Fig. 8E). The presence of inﬁltrating tumorous
glial cells attested by high magniﬁcation histological observation
(irregular atypical cell nuclei compared to normal oligodendrocytes)
is not detectable with the current generation of FF-OCT devices, as
FF-OCT cannot reliably distinguish the individual cell nuclei due to
lack of contrast (as opposed to lack of resolution). In our experience,Fig. 3. Hippocampus. CA1 ﬁeld and stratum radiatum, CA4 ﬁeld, the hippocampal ﬁssure, the
CA4, and (C–D) granular cells constitute the stratum granulosum of the dentate gyrus. (A an
show 40 μm (A, B), 80 μm (C, D), and 900 μm (E).diffuse low-grade gliomas (less than 20% of tumor cell density) are
mistaken for normal brain tissue on FF-OCT images. However, in
high-grade gliomas (Fig. 8G–K), the inﬁltration of the tumor has
occurred to such an extent that the normal parenchyma architecture
is lost. This architectural change is easily observed in FF-OCT and is
successfully identiﬁed as high-grade glioma, even though the individual
glial cell nuclei are not distinguished.dentate gyrus, and the alveus are distinguished. (A–B) Pyramidal neurons (arrows) of
d C) Hemalun and phloxin stainings. Rectangles indicate locations of zooms. Scale bars
Fig. 4. Cerebellum. Banding artifacts in this image result from ﬁeld illumination inhomogeneity due to imperfect alignment of the optical set-up, an artifact that has been minimized
in subsequent FF-OCT setups. (A–B) The lamellar or foliar pattern of alternating cortex and central white matter. (C–D, E–F) Zooms show cerebellar cortex and granular layer, and
(E–F) Purkinje (arrow) and granular neurons are distinguished as black triangles or dots, respectively, and myelinated axons as bright white lines. (B, D and F) Hemalun and phloxin
stainings. Rectangles indicate locations of zooms. Scale bars show 800 μm (A, B), 350 μm (C, D), and 100 μm (E, F).
Fig. 5. (A) Meningioma psammoma. (B–C) Collagen bundles, (D–E) whorls, (F–G) calciﬁcations, and (H–I) collagen balls. (C, E, G and I) Hemalun and phloxin stainings. Rectangles
indicate locations of zooms. Scale bars show 500 μm (A), 50 μm (B, C), and 10 μm (D, E, F, G, H, I).
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Fig. 6. Hemangiopericytoma. (A–B) Collagen network and branching vascular space. Staghorn sinusoids appear white. (C–D) Vessel. (B and D) Hemalun and phloxin stainings. Scale
bars show 250 μm.
555O. Assayag et al. / NeuroImage: Clinical 2 (2013) 549–5574. Discussion
We present here the ﬁrst large size images (i.e. on the order of
1–3 cm2) acquired using an OCT system that offer spatial resolution
comparable to histological analysis, sufﬁcient to distinguish micro-
structures of the human brain parenchyma.
Firstly, the FF-OCT technique and the images presented here
combine several practical advantages. The imaging system is com-
pact, it can be placed in the operating room, the tissue sample doesFig. 7. (A) Papilloma — cauliﬂower-like aspect. (B–E) Empty papilla, (C–D) blood ﬁlled papi
Rectangles indicate locations of zooms. Scale bars show 150 μm (A), 50 μm (B, C, E, F), 20 μnot require preparation and image acquisition is rapid. This technique
thus appears promising as an intraoperative tool to help neurosurgeons
and pathologists.
Secondly, resolution is sufﬁcient (on the order of 1 μm axial and
lateral) to distinguish brain tissue microstructures. Indeed, it was
possible to distinguish neuron cell bodies in the cortex and axon bun-
dles going towards white matter. Individual myelin ﬁbers of 1 μm in
diameter are visible on the FF-OCT images. Thus FF-OCT may serve
as a real-time anatomical locator.lla, and (D–G) single layer of plexus cells. (E, F and G) Hemalun and phloxin stainings.
m (D, G).
Fig. 8. Glioma. Three different cases are shown here (A–B; C–F; G–L). (A–B) Microcysts
(arrows) in an oligo-astrocytoma grade 2; (C–D) microcystic areas and Virchow–Robin
space (arrows) in an astrocytoma grade 2; (E–F) enlarged Virchow–Robin spaces in an
astrocytoma grade 2; (G–H) microvessels (arrow) and tumorous glial cells in an oligo-
astrocytoma grade 3; and (I–J) pseudo-palisading necrosis in an oligo-astrocytoma grade
3. Necrosis appears as dark diamond shaped area. White powdery substance in center of
dark space (white arrow) is lysed cells (necrotic cells/centers). Dark arrow on histology
shows a vessel. (K–L) Vasculature (arrows) in an oligo-astrocytoma grade 3 is immediately
visible in white in FF-OCT images, while in histology an additional coloration is required to
visualize this feature. (B, D, F, H and J) Hemalun and phloxin stainings and CD34 immuno-
staining (L). Scale bars show 250 μm (A, B), 100 μm (C–F), 20 μm (G, H), and 10 μm (I–L).
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brous, transitional and psammomatous meningiomas were easily rec-
ognizable on the FF-OCT images (lobules and whorl formation,
collagenous-septae, calciﬁed psammoma bodies, thick vessels).
Psammomatous and transitional meningiomas presented distinct ar-
chitectural characteristics in FF-OCT images in comparison to those
observed in hemangiopericytoma. Thus, FF-OCT may serve as an
intraoperative tool, in addition to extemporaneous examination, to
reﬁne differential diagnosis between pathological entities with differ-
ent prognoses and surgical managements.
Diffuse glioma was essentially recognized by the loss of normal
parenchyma architecture. However, glioma could be detected on
FF-OCT images only if the glial cell density is greater than around
20% (i.e. the point at which the effect on the architecture becomes no-
ticeable). The FF-OCT technique is therefore not currently suitable for
the evaluation of low tumorous inﬁltration or tumorous margins.
Evaluation at the individual tumor cell level is only possible by
IDH1R132 immunostaining in IDH1 mutated gliomas in adults
(Preusser et al., 2011). One of the current limitations of the FF-OCT
technique for use in diagnosis is the difﬁculty in estimating the nucle-
ar/cytoplasmic boundaries and the size and form of nuclei as well as
the nuclear-cytoplasmic ratio of cells. This prevents precise classiﬁca-
tion into tumor subtypes and grades.
To increase the accuracy of diagnosis of tumors where cell density
measurement is necessary for grading, perspectives for the technique
include development of a multimodal system (Harms et al., 2012) to
allow simultaneous co-localized acquisition of FF-OCT and ﬂuores-
cence images. The ﬂuorescence channel images in this multimodal
system show cell nuclei, which increase the possibility of diagnosis
and tumor grading direct from optical images. However, the use of
contrast agents for the ﬂuorescence channel means that the multi-
modal imaging technique is no longer non-invasive, and this may
be undesirable if the tissue is to progress to histology following op-
tical imaging. This is a similar concern in confocal microscopy where
use of dyes is necessary for ﬂuorescence detection (Wirth et al.,
2012).
In its current form therefore, FF-OCT is not intended to serve as a
diagnostic tool, but should rather be considered as an additional
intraoperative aid in order to determine in a short time whether or
not there is suspicious tissue present in a sample. It does not aim to
replace histological analyses but rather to complement them, by offer-
ing a tool at the intermediary stage of intraoperative tissue selection.
In a few minutes, an image is produced that allows the surgeon or the
pathologist to assess the content of the tissue sample. The selected tis-
sue, once imaged with FF-OCT, may then proceed to conventional his-
tology processing in order to obtain the full diagnosis (Assayag et al.,
2013; Dalimier and Salomon, 2012).
Development of FF-OCT to allow in vivo imaging is underway, and
ﬁrst steps include increasing camera acquisition speed. First results of
in vivo rat brain imaging have been achieved with an FF-OCT proto-
type setup, and show real-time visualization of myelin ﬁbers (Ben
Arous et al., 2011) and movement of red blood cells in vessels
(Binding et al., 2011). To respond more precisely to surgical needs,
it would be preferable to integrate the FF-OCT system into a surgical
probe. Work in this direction is currently underway and preliminary
images of skin and breast tissue have been captured with a rigid
probe FF-OCT prototype (Latrive and Boccara, 2011).
In conclusion, we have demonstrated the capacity of FF-OCT for im-
aging of human brain samples. This technique has potential as an
intraoperative tool for determining tissue architecture and content in
a few minutes. The 1 μm3 resolution and wide-ﬁeld down to cellular-
level views offered by the technique allowed identiﬁcation of features
of non-tumorous and tumorous tissues such as myelin ﬁbers, neurons,
microcalciﬁcations, tumor cells, microcysts, and blood vessels. Corre-
spondence with histological slides was good, indicating suitability
of the technique for use in clinical practice for tissue selection for
557O. Assayag et al. / NeuroImage: Clinical 2 (2013) 549–557biobanking for example. Future work to extend the technique to in vivo
imaging by rigid probe endoscopy is underway.
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